TTX-01

N/A

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameTTX-01
Drug Alias Name2P-ImCDDO-2-pyridyl imidazolideCDDO-2P-Imsynthetic triterpenoid CDDO-2-pyridyl imidazolide (Triterpenoid Therapeutics)CDDO-2P-Im (Triterpenoid Therapeutics) +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 inhibitors
TargetsNACHT, LRR and PYD domains-containing protein 3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGeisel School Of MedicineTriterpenoid Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGeisel School Of Medicine
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A